Free Trial
→ Altucher: $900 to $108,000? Trump’s “Great Gain” Is Here (From Paradigm Press) (Ad) Free NBY Stock Alerts

NovaBay Pharmaceuticals (NBY) SEC Filings & 10K Form

NovaBay Pharmaceuticals logo
$0.59 +0.01 (+1.84%)
Closing price 08/8/2025 04:10 PM Eastern
Extended Trading
$0.66 +0.06 (+10.55%)
As of 08/8/2025 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent NovaBay Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
06/04/2025
11:46 AM		NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D
04/15/2025
11:40 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:46 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:50 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:11 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:18 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:22 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:30 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:30 PM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:33 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEF 14A
03/11/2025
3:35 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:07 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:08 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
02/06/2025
5:30 PM		NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
3:58 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:58 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
01/23/2025
7:12 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
01/23/2025
7:13 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
3:27 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
5:06 PM		NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G
01/10/2025
6:03 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
6:00 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:12 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
12/09/2024
6:05 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/26/2024
3:08 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/22/2024
3:27 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
7:10 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/13/2024
4:15 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/12/2024
3:52 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
11/08/2024
4:31 PM		Hudson Bay Capital Management LP (Filed by)
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
Form SC 13G/A
11/06/2024
3:46 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:15 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:19 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
10/16/2024
3:27 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:19 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFM14A
09/25/2024
4:17 PM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form PREM14A
09/20/2024
7:08 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
7:08 AM		NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSEAMERICAN:NBY) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
National 'Stock Market Reset' Coming September 30 (New WH Order)
Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...
Altimetry | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
Green Light for These Stocks
Guess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...
Stansberry Research | Sponsored
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsored
Sell this, buy that
What you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...
InvestorPlace | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored